Pediatric cancer recurrence is a critical concern for families and healthcare providers alike, especially in cases involving brain tumors like gliomas.Recent advancements in pediatric oncology have highlighted the role of AI cancer prediction tools that analyze MRI scans over time, significantly improving the accuracy of relapse risk assessments.